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Intracellular Nanoparticle Dynamics Affected by Cytoskeletal 
Integrity
Martha E. Gradya,b,†,‡, Emmabeth Parrishb,†, Matthew A. Caporizzob, Sarah C. Seegera,b, 
Russell J. Compostob,⊥, and David M. Eckmanna,⊥,*
aDepartment of Anesthesiology and Critical Care, School of Medicine, University of Pennsylvania, 
USA
bDepartment of Materials Science and Engineering, School of Engineering and Applied Science, 
University of Pennsylvania, USA
Abstract
The cell interior is a crowded chemical space, which limits the diffusion of molecules and 
organelles within the cytoplasm, affecting the rates of chemical reactions. We provide insight into 
the relationship between non-specific intracellular diffusion and cytoskeletal integrity. Quantum 
dots entered the cell through microinjection and their spatial coordinates were captured by 
tracking their fluorescence signature as they diffused within the cell cytoplasm. Particle tracking 
revealed significant enhancement in the mobility of biocompatible quantum dots within 
fibrosarcoma cells versus their healthy counterparts, fibroblasts, as well as in actin destabilized 
fibroblasts versus untreated fibroblasts. Analyzing the displacement distributions provided insight 
into how the heterogeneity of the cell cytoskeleton influences intracellular particle diffusion. We 
demonstrate that intracellular diffusion of non-specific nanoparticles is enhanced by disrupting the 
actin network, which has implications for drug delivery efficacy and trafficking.
Introduction
Actin and tubulin form highly versatile, dynamic polymers that are fundamental to creating 
the spatial organization of eukaryotic cells through cytoskeletal structures. These 
cytoskeletal systems are dynamic and adaptable, capable of organizing intracellular 
compartments, and are critical to a number of cell processes including cell migration and 
division. Inside these compartments is a crowded chemical space in which the volume 
fraction of macromolecules can reach up to 40%.1 This large volume fraction limits 
diffusion of molecules and organelles within the cytoplasm and therefore affects the rates of 
chemical reactions in the cell. A contributor to this confinement is the cytoskeleton itself, 
which features a mesh-like network with open spaces that direct the diffusion of 
macromolecules. The structural role of the actin and microtubule network within cell 
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mechanics has been previously investigated2–4 and together with the whole cytoskeleton 
network, cytoplasmic organelles, and molecular crowding, serves as obstacles to non-
directed intracellular motion. Intracellular particle diffusion has become increasingly 
important within nanomedicine, where nano-scale photodynamic therapies5–7 and gene or 
drug delivery systems8–11 have made significant advances in disease treatment options. The 
effect of the cytoskeleton on the diffusion of nanoparticles brings into question the relative 
size scales between the mesh and the translocating objects. The actin network has been 
reported to have a heterogeneous mesh size ranging from 30–100 nm (Luby-Phelps12) to 
300–600 nm (Kusumi et al.13) across mammalian cells. More recently, Kronlage et al.14 
measured the open pore size within the actin cytoskeleton of endothelial cells under control 
conditions of approximately 10,000 nm2 (about 100 nm square) and under cytochalasin D 
treatment, the open area increases to above 30,000 nm2 (173 nm square). When particle size 
is similar to or greater than the cytoskeletal mesh, the resulting confinement allows for the 
measuring of the microrheological properties of the cell interior.15, 16 Alternatively, particles 
smaller than the mesh are subjected to a different microenvironment than larger particles. 
The different local environment will affect the diffusivity of small particles, critical in 
nanoparticle-based therapies or diagnostics. For example, in endosomal release of 
theranostic nanomaterials (e.g., nanoparticle mediated siRNA delivery8, 9), particles must 
translocate to an alternative intracellular site (e.g., the nucleus), where they accumulate for 
efficacy of the therapy. To determine the potential for accumulation and therefore the 
efficacy of these nanoparticle therapies, we must understand the dynamics involved in 
intracellular nanoparticle diffusion. Here we discuss the influence of cytoskeletal integrity, 
namely filamentous actin and microtubules, on intracellular nanoparticle diffusion 
manifested in different cell conditions. Motivated by prior elasticity measurements,2 we 
identify differences between two cell types, one cancer (fibrosarcoma cells HT 1080) and 
one non-cancer (human dermal fibroblasts), as well as drug-altered cytoskeletons within 
those two lines by cytochalasin D treatment (disrupts filamentous actin) and nocodazole 
treatment (disrupts microtubules). Within the cytoplasm of these cells, the nanoparticles act 
as internal probes that reflect the influence of the cytoskeleton and its caged network on 
transport. Analysis of the nanoparticle paths further provides quantitative values of diffusion 
coefficients that drug carrier and similarly sized biomaterials have inside healthy and 
diseased cells.
Candidates for assessing intracellular trafficking include tracking small fluorescent 
molecules using FRAP17 or FCS18, or tracking micron and sub micron particles using single 
particle tracking (SPT)19 or extensions thereof.15 Particle mobility has also been studied as a 
probe of local viscosity in the field of microrheology.20 Labeling a few molecules by 
fluorescent dyes can achieve high temporal resolution but lack the lateral/spatial resolution 
that SPT can achieve. SPT can be limited by photobleaching of fluorophores if used, and the 
inability to track particles that travel perpendicular to the imaging plane. However, SPT has 
been shown to be well suited to the study of living cell interiors.19, 21–25 Quantum dots 
(QDs) present a unique opportunity for stable particle tracking as they are not subject to 
photobleaching and can be synthesized to respond to a variety of chosen wavelengths as well 
as include a chemically grafted outer shell either to confer, or to prevent, specific biological 
interactions. SPT of QDs within the cellular environment has been used to investigate 
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specific cellular processes such as insulin receptor activity,26 virus infection,27, 28 calcium 
flux detection,29 and kinesin motor transport.30 Polymer coated nanoparticles have also been 
used in treatment regimes such as targeted killing of tumor cells5, 6 and alleviating liver 
damage.31 Once inside the cell, SPT has revealed dynamic properties of delivered particles. 
Freely diffusive particles (Brownian motion) have a linear relationship between time and 
mean square displacement (MSD), however, intracellular transport typically results in 
subdiffusive or confined behavior, i.e., movement of particles with less than t1 dependence.4 
The distinction between Brownian motion and subdiffusive motion in the cellular 
environment is extremely important: if particles are confined, the time and even ability to 
reach a desired intracellular destination will be affected. Identifying which cellular 
components contribute to this confinement is critical to understanding intracellular transport.
Our results indicate that the diffusion of small, polymer-grafted QDs is sensitive to 
cytoskeletal modifications, particularly actin network connectivity. Unlike preceding QD 
intracellular tracking experiments32 these QDs have no specific affinity for binding within 
the cell. The PEG coating on our QDs has been shown repeatedly to be the most highly non-
interacting polymer coating for cellular environments.21, 33 We demonstrate that 
heterogeneity in the actin network either manifested by cell type or by disruption of 
cytoarchitecture within healthy cell types results in a change in nanoparticle dynamics thus 
signifying that the cytoskeleton organization can act as a barrier for non-motor driven 
intracellular trafficking.
Results and Discussion
In our work, CdSe quantum dots (4 nm) were grafted with a biocompatible PEG34 brush 
(Mw=5 kDa) that neither interacts with intracellular components nor is toxic to the cell. For 
example, prior work shows that Ag nanoparticles are toxic to THP-1 cells resulting in a 
change in cell viscoelasticity with a two fold increase in complex modulus.35 The PEG 
grafted QDs have a hydrodynamic diameter of 10 nm, determined by diffusion in 
glycerol:water with known viscosity (supplementary materials). QDs entered each cell by 
microinjection using an Eppendorf Injection system (supplementary materials), which 
provides a fast introduction (0.5 s) of QDs by pressure-driven injection of small liquid 
volumes. The micropipettes had an outer diameter of 1 μm. The delivery and diffusion of 
QDs were monitored throughout the cell cytoplasm. We manipulated the needle by using a 
common piezoelectric micromanipulator integrated with a Nikon inverted epifluorescence 
microscope with 100× oil-immersion objective. The needle was manipulated to approach 
and penetrate the cell at an angle of 30 degrees from the surface plane. During QD delivery, 
we could precisely locate the needle in the cellular environment in brightfield and 
fluorescence imaging mode. The photo stability of QDs allowed continuous observation of 
QDs for the duration of video capture, which was between 5 and 10 minutes.
To quantify the QD dynamics, we carried out SPT using free software to connect particle 
centers of mass across images, obtaining particle trajectories.36 Figure 1a–c includes a 
subset of 50 particle trajectories from QDs in the cytoplasm of fibroblasts, fibrosarcoma 
cells, and cytochalasin D treated fibroblasts as well as an overlay of all 699, 634, and 353 
trajectories, respectively.
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The QDs within the fibrosarcoma cell cytoplasm had greater mobility than within the 
fibroblast possibly because the cytoskeletal network is more disorganized. For example, in 
model mouse ovarian cancer cells, in addition to changes in gene expression levels, the 
cytoskeleton structure became increasingly disorganized during neoplastic progression.37 
Other reports confirm the deformation capacity of cancer cells (and metastatic potential) is 
due to differences in the cytoskeleton and nuclear protein organization.38–42
To test if the particular organization of microfilaments within the fibrosarcoma cell line 
contributed to a change in the mobility of the QDs, cytochalasin D was used to disrupt the 
filamentous actin network in fibroblasts to achieve less organization. This treatment resulted 
in a longer mean free path of the QD consistent with the comparison between fibroblasts and 
fibrosarcoma cells (see supplementary materials for actin staining). We also investigated 
how QD diffusion was influenced by the breakdown of the microtubule network induced by 
nocodazole treatment. We found that the mobility of QDs within fibroblasts was less 
affected by nocodazole treatment than cytochalasin D treatement, which is consistent with 
prior studies showing that the mechanical properties of fibroblasts do not change 
significantly when exposed to nocodazole.2 From the particle tracks, MSD was determined 
using MATLAB43. MSDs for QDs within fibroblasts, fibrosarcoma cells, and cytochalasin D 
treated fibroblasts are shown in Figure 1d–f respectively. To compare ensemble differences, 
we analyzed the particle trajectories using (1) the center of the MSD distributions at a range 
of delay times to compare overall mobility, (2) a power law fit to the data to extract diffusion 
parameters, and (3) step sizes at particular temporal windows to probe local dynamic 
heterogeneity.
At a delay time of 1 s, Figure 2 shows the MSD for QDs in fibroblasts, fibrosarcoma cells, 
and fibroblasts treated with cytochalasin D. Although the MSD has a broad distribution in all 
cases, QDs within the fibrosarcoma cell cytoplasm travel the furthest with a MSD geometric 
average near 6 × 104 nm2 compared to the fibroblast case centered near 6 × 103 nm2. After 
exposing fibroblasts to cytochalasin D, the MSD values broadened and the geometric center 
value increased to 3 × 104 nm2 an order of magnitude increase over the fibroblast case and 
only 50% less than the fibrosarcoma cell value. These relationships persist at shorter and 
longer delay times, namely t = 0.5 s and 3 s. For fibroblasts, the breadth and number of 
tracks with MSDs greater than 104 nm2 significantly increased upon exposure to 
cytochalasin D suggesting an increase in mobility and less confinement of QDs during 
diffusion. Interestingly, MSD values for fibroblasts and cytochalasin D treatment correspond 
to the open spaces within the actin network measured by Kronalge14 within endothelial 
cells.
As demonstrated by previous particle dynamics researchers, particles within cells tended 
toward subdiffusive rather than Brownian motion with a few exceptions.4 The MSD for 
diffusion can be given by MSD = 2Dtα where D is the diffusion coefficient, t is time, and α 
is the power law exponent. A power law was fit to each condition and sorted for those 
trajectories with r2 values greater than 0.7 (43% of trajectories within fibroblasts and 72% of 
trajectories within fibrosarcoma cells fit this criteria). For QDs diffusing in fibrosarcoma 
cells, the power law exponents centered around 0.75 whereas for fibroblasts, alpha was 
lower, centered around 0.60 as shown in Figure 3. Thus, QDs within the cytoplasm of 
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fibrosarcoma cells experienced less confinement. When the actin network of fibroblasts was 
disrupted using cytochalasin D, decreasing network confinement, the power law exponent 
increased to 0.70 representing a shift toward Brownian motion but still exhibiting sub-
diffusive behaviour. Alternatively, when the actin network of fibrosarcoma cells was 
disrupted, power law exponents for QDs within fibrosarcoma cells were minimally affected 
by cytochalasin D treatment (supplementary materials). Diffusion coefficients were 
determined from tracks with alphas between 0.75 and 1.25. The percentage of tracks that fall 
into this range are 12% and 33% for fibroblasts and fibrosarcoma cells, respectively. For 
QDs within fibroblasts, the diffusion coefficient was 4 × 104 nm2/s, whereas QD diffusion 
was twice as high in fibrosarcoma cells, 9 × 104 nm2/s.
Destabilizing the actin of the fibroblasts increased the diffusion coefficient to 13 × 104 
nm2/s, which is three times higher than in the control cells and larger than fibrosarcoma 
cells. These diffusion coefficients are smaller than expected for QD diffusion in water, (the 
main solvent of the cytosol) which is attributed to obstacles such as organelles and 
cytoskeletal network in the cytoplasm12. A significant finding of this study is that small 
particles move faster and further upon disrupting the actin cytoskeletal network. While 
diffusion coefficients are extracted from particles that followed Brownian motion, these 
parameters represent a smaller subset of the particles. Most particles experienced confined 
motion and a more detailed analysis of particle step size provides further insight into the 
overall response of QDs to the cell cytoplasm.
The distribution of QD displacements provides further insight into the nanoscale 
environment and dynamic heterogeneity experienced by the QDs. The van Hove correlation 
function, Δ, describes the probability of a particle moving a distance along a single axis 
within a specific time interval, τ.44 The self-portion, the average motion of the particle 
initially at the origin, is given by Δ=x(t+τ)−x(t) and y(t+τ) −y(t) for steps in the × and y 
directions, respectively.45 The van Hove distributions were calculated using the above 
equation for Δ and normalizing the area under the curves to one. The van Hove distributions 
for fibroblast, fibroblast cells exposed to cytochalasin D, fibrosarcoma cells, and 
glycerol:water are displayed in Figure 4. The van Hove distribution is Gaussian for spatially 
homogenous environments46 and was observed for QDs within homogeneous glycerol:water 
solutions (Figure 4d). While all cell distributions (Figure 4a–c) clearly deviate from 
Gaussian and exhibit central peaks at all time intervals, the larger displacement tails are 
qualitatively and quantitatively different. As seen by the area under the displacement 
distribution in Figure 4a, the majority of QDs within fibroblast cells were confined to 
displacements of 200 nm, while larger displacements had a low likelihood of occurring. 
Additionally, displacements larger than 1000 nm were not realized in fibroblast cells at a 
time interval of 1 s. The limited time dependence, evidenced by the nearly overlapping 
values at all time intervals, indicates QDs in fibroblast cells were exploring a confined 
spatial region. Displacement distributions of QDs within fibroblast cells exposed to 
cytochalasin D display a greater likelihood of large displacements, as seen by the increased 
area under the curve in Figure 4c. The distributions display an increasing range of motion 
with increasing time from 0.12 to 0.6 s, indicating that the QDs explored a greater spatial 
area. A smaller change is seen from 0.6 to 1 s, commensurate with the MSD and alpha 
distributions, which display greater, but still confined, QD mobility. Similar behavior is seen 
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for QDs within the fibrosarcoma cells, Figure 4b. QD displacements were larger, even at 
0.12 s, than QD displacements within fibroblast cells. While the central Gaussian peaks 
correspond to displacements bounded by approximately ±200 nm for all conditions, the tails 
of the distribution exhibit an exponential dependence that can be quantified by characteristic 
lengths, Table 1. Studies on particle dynamics in F-actin solutions47 have established that the 
exponential tails reflect the interaction between particle and environment. For our study, 
these length scales indicate the degree of confinement of QDs by their local environment. 
The characteristic lengths of the QD displacement distribution tails within fibroblasts 
changed negligibly with increasing time, from 96 nm to 115 nm at time intervals of 0.12 s 
and 1 s, respectively. For fibroblast cells exposed to cytochalasin D, however, the 
characteristic length increased from 193 to 328 nm from 0.12 to 1 s. Fibrosarcoma cells 
show an increase in characteristic length from 130 to 224 nm over the same time interval. 
The characteristic length of the fibrosarcoma cells exposed to nocodazole decreased to 98 
nm and 140 nm from control values of 130 nm and 224 nm, respectively at time intervals of 
0.12 and 1 s corresponding to a decrease in mobility (Supplementary Material). The 
displacement distributions and characteristic lengths of QDs within fibroblast cells exposed 
to nocodazole and QDs within fibrosarcoma cells exposed cytochalasin D, display behaviors 
similar to their control condition (Supplementary Material).
The differences observed in the displacement distributions can be explained by changes in 
the nanoscale environment the QDs experience. In fibroblasts, QDs were confined by the 
actin network, which is heterogeneous, yet has a mesh dimension on the order of 400 nm 
consistent with the central peak of the distribution, ±200 nm, that confines the majority of 
the QD displacements. Studies on nanoparticle mobility within gels48 have used the central 
Gaussian portion of the van Hove to characterize caging lengths. In the case of QDs within 
the cell cytoplasm, we assert that the relevant caging length scale is the average mesh size. 
In fibroblasts, escaping a primary mesh and traveling to a neighbouring mesh is a rare event, 
resulting in a drastically different environment experienced by the QD. In comparison to 
published research on the mesh size of the actin network, values of 100–200 nm12,14 are 
more prevalent than values of 300–600 nm13 for fibroblast cell lines. The actin mesh size is 
cell type dependent as well as locally heterogeneous as the network undergoes densification 
toward the cell periphery. Our experiments avoid the cell periphery and thus would expect a 
slightly larger mesh size as a result. In fibroblasts exposed to cytochalasin D, the actin 
network was disrupted (supplementary materials). While a primary mesh of 400 nm exists in 
some areas demonstrated by the van Hove distribution width, the connectivity of the network 
has decreased, homogenizing the distribution of mesh sizes. This loss of connectivity 
increases the probability of QDs moving between primary meshes, allows QDs to explore 
more area with increasing time, and decreases the confinement experienced by QDs within 
the cytoplasm, ultimately leading to increased QD mobility. In fibrosarcoma cells, the 
disorganized actin cytoskeleton (supplementary materials) allows QDs to move between 
primary meshes, to explore more area with increasing time, and to experience less 
confinement from the actin cytoskeleton. These disparate dynamic behaviors of 
nanoparticles in different cell lines and conditions indicate differences in the local 
microenvironment.
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The use of nanoparticles as probes to understand complex environments spans many fields, 
from industrially relevant polymer gels to extracellular polymer networks.49, 50 Additionally, 
non-Gaussian dynamics, specifically displacement distributions with exponentially decaying 
tails, have been observed in a wide variety of nano and micron scale systems, such as 
colloidal suspensions,51 solutions of f-actin,47 and recently, live muscle cell membranes.11 
Our study shows nanoparticles within the cell cytoplasm also move in a non-Gaussian 
manner, indicating the ubiquitous nature of non-Gaussian dynamics and calling for enhanced 
models to determine diffusion properties when Gaussian relationships do not hold. Also, the 
dynamic behavior of QDs provided spatial information about the altered cytoskeletal 
networks, including average mesh size and changes in the mesh hindrance.
Geometric mean MSDs are shown in Figure 5 for all QD particle tracks within this study, 
which summarizes QD diffusion within each cell line and drug condition. The geometric 
mean was chosen to represent the central tendency because the distribution of values did not 
follow a standard normal distribution. QDs within fibroblasts and fibroblasts treated with 
nocodazole (microtubule disruption) exhibited the lowest MSDs. Disrupting the actin 
network with cytochalasin D treatment resulted in a significant increase (order of 
magnitude) in MSD whose behavior becomes similar to the fibrosarcoma results. Disruption 
of the cytoskeletal elements within fibrosarcoma cells with either nocodazole or cytochalasin 
D resulted in a decrease in MSD. QD mobility increased by an order of magnitude within 
fibrosarcoma cell cytoplasm compared to within the fibroblast cytoplasm.
Altering the connectivity of the actin network within fibroblasts resulted in QD mobility 
similar to that of QDs within the untreated fibrosarcoma cell cytoplasm. The intrinsic 
differences between the two cell lines result in vastly different intracellular particle mobility. 
What this research demonstrates is the sensitivity of intracellular QD diffusion to actin 
cytoskeletal modifications. Not all cytoskeletal modifications had equal effects, as 
nocodazole treatment, which attacks the microtubule network, had little effect on the MSD 
of QDs within the fibroblast cytoplasm. Interestingly, actin and microtubule disruption of 
fibrosarcoma cells resulted in slightly decreased mobility of QDs within the cytoplasm. One 
possibility is that the local microviscosity of the fibrosarcoma cells experience a greater 
change in response to the toxins than the fibroblasts. Measures of elasticity of the same cell 
lines indicated a stiffening behavior in the fibrosarcoma line in response to microtubule 
disruption.2
Experimental Methods
Cell culture
Human dermal fibroblasts and HT 1080 (fibrosarcoma cells). Fibroblasts were cultured in 
Fibrolife (Lifeline Cell Technologies) were cultured for this study. All cells were incubated 
at 37 °C in a humidified atmosphere with 5% CO2. Dishes and coverslips were coated for 
30–40 min with 5 μg/mL fibronectin (BD Biosciences) dissolved in PBS prior to plating. 
Cells were initially plated at 75–100k density on glass coverslips (22 × 40 mm) for all 
studies, and were incubated for 48 hrs prior to experiments. Three conditions were studied: 
control (recording buffer only), 2.5 μM Cytochalasin D (Sigma Aldrich) in recording buffer 
for 30 min, and 10 μM Nocodazole (Sigma Aldrich) in recording buffer for 30 min.
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Cell injection
A Nikon Eclipse Ti inverted fluorescence microscope was paired with an Eppendorf 
InjectMan4 micromanipulator and Eppendorf FemtoJet4i pressure injector. QDs were 
dispersed in DI water at 0.2 nM concentration and loaded into Eppendorf Femtotips. Typical 
input pressure values used were 200–400 hPa. Injections lasted 0.5 to 1 s. An x–y stage 
mounted to the microscope platform allowed the movement of the cell-coated coverslip into 
different viewing windows.
Particle tracking
Videos were recorded in brightfield before injection, then fluorescence just after injection, 
and finally brightfield again to examine the cell. Particle tracking software, FIESTA, was 
used to extract particle tracks from the fluorescence signature of QDs within the recorded 
videos. A frame rate of 16.9 fps was used and the calibration of the objective was 110 nm 
per pixel. The FIESTA program applies a Gaussian fit to the fluorescence to determine the 
center of the fluorescence with nm precision. A selection box was used to identify 
approximate cell boundaries and to limit the run time of the program by excluding areas 
outside of the cell from analysis. Drift was evaluated using immobilized QDs and found to 
be on the order of error in positioning. Particle tracks with an average positioning error 
greater than 25 nm were excluded from analysis.
Conclusions
Although our method could be employed to observe a variety of dynamic biological events, 
we have placed an emphasis on evaluating the effect of the cytoskeletal network on non-
directed diffusion as opposed to active motor-driven transport. We have compared fibroblasts 
and fibrosarcoma cells with two cytoskeletal destabilizers acting on distinct elements. The 
results indicate that non-specific transport of nanoscale particles is inhibited by confinement 
due to the actin network. This is an intriguing phenomena brought on by small size scales; 
the nanoscale particles are affected by a mesoscale network, which shifted nanoparticle 
mobility toward subdiffusive, non-Gaussian dynamics more than would be expected simply 
due to the viscous material present between the mesh. In our work, the influence of 
intermediate filaments has not been explored. According to Guo et al.,52 intermediate 
filaments may play a role in intracellular dispersion of larger organelles within cells. 
Specifically, the tracking of endogenous vesicles within mouse embryonic fibroblasts 
revealed increased motility in cells that lack vimentin intermediate filaments. We anticipate 
further studies to elucidate the effects of intermediate filaments on small particle transport. 
Further extensions of our work include probing the effects of bridging proteins (e.g., plectin, 
septins, myosin filaments), DNA linking, motor driven transport, and implications for 
understanding nanoparticle trafficking and therapeutics in diseased cells. Specifically, many 
anti-cancer drugs target the destabilization of filamentous actin and microtubule spindle 
dynamics.10 From our study, anti-cancer drugs that disrupt the cell architecture would not 
greatly affect the dynamics of nanoparticle drug carriers within cancerous cells, but would 
increase transport of the nanoparticles within the surrounding healthy tissues should the drug 
carriers also enter these cells. In conclusion, we have demonstrated that the relationship 
between nanoparticle dynamics and cytoskeletal integrity is of critical importance to 
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particles smaller than the mesh size, which leads to changes in confinement, diffusion 
parameters, and even the ability of a nanoparticle to reach a desired intracellular destination.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Individual QD particle trajectories (50) within (a) fibroblasts, (b) fibrosarcoma cells, and (c) 
fibroblasts with cytochalasin D treatment with overlay insets where trajectories are 
initialized at (0,0) and include all 699, 634, and 353 trajectories recorded, respectively. Mean 
squared displacements (MSD) of QDs within (d) fibroblasts, (e) fibrosarcoma cells and (f) 
fibroblasts with cytochalasin D treatment. Color scale used to indicate higher MSD is carried 
through for individual particle tracks in (a–c).
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Figure 2. 
Histogram of log of MSDs at a delay time of 1 s for QDs within (a) fibroblasts, (b) 
fibrosarcoma cells, and (c) fibroblasts with cytochalasin D treatment.
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Figure 3. 
Histogram of power law diffusion exponent, α, for QDs within control fibroblasts (Fibro, 
blue solid), fibrosarcoma cells (Fsarcoma, red), and fibroblasts with cytochalasin D 
treatment (Fibro+Cyto, blue hash). Distribution centers are noted with vertical lines for each 
distribution.
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Figure 4. 
van Hove distributions for QDs within (a) fibroblasts, (b) fibrosarcoma cells, (c) fibroblasts 
with cytochalasin D treatment, and (d) 90% glycerol:water solution at three time increments 
of 0.12 s, 0.6 s, and 1 s. Step size, Δ, combines steps in both × and y into a single van Hove 
distribution.
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Figure 5. 
Geometric mean MSD for each of six conditions. Nomenclature is as follows: fibrosarcoma 
cells (FSarcoma), fibroblasts (Fibro), cytochalasin D treatment (Cyto), nocodazole treatment 
(Noco). Error bars are standard error.
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Table 1
Characteristic lengths extracted from van Hove distributions for fibroblasts (Fibro), fibrosarcoma cells 
(FSarcoma), and fibroblasts treated with cytochalasin D (Fibro+Cyto).
Cell Type Time (s) Characteristic Length (nm)
Fibro
0.12 96.0
0.6 101.2
1.0 114.9
FSarcoma
0.12 129.4
0.6 187.0
1.0 224.4
Fibro+Cyto
0.12 192.9
0.6 297.6
1.0 328.4
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